Welcome to SIR

The Italian Society of Rheumatology (SIR) is committed to optimising and developing projects in the field of scientific research, education and health care in rheumatology.

SIR encourages every initiative, whether public or private, designed to help the sick and to prevent and treat rheumatic diseases.

Therefore, SIR promotes groups, committees and commissions for studies and research in the field of rheumatic diseases, connective tissue and of the musculoskeletal system, disseminating the knowledge acquired both on scientific and social aspects.

Education, training and social and health care are among the activities to which the SIR dedicates their constant attention.

This commitment is expressed in a variety of activities such as conferences, round tables and workshops on rheumatic diseases, publication of documents, studies and research, development of guidelines and diagnostic-therapeutic protocols, collaboration with institutional authorities in the drafting of documents that provide incentives for prevention and the treatment of rheumatic diseases, coordinating of the exchange of information between specialist centres, hospitals, regional institutions and family physicians, making the pharmaceutical industry aware of specific research in the field of Rheumatology, promotion of large-scale epidemiological studies aimed at obtaining precise data on the incidence of rheumatic diseases, their spread, the prospects for treatment and the protection of patients' rights, with particular reference to the right to an early diagnosis and to appropriate and timely care.

Among the initiatives of the SIR is the national register of patients with rheumatoid arthritis treated with biologics, launched through a partnership between the SIR and AIFA (Italian Medicines Agency). The registry is an effective tool to monitor over time the evolution of the disease and the occurrence of side effects in patients treated with these drugs.

The SIR has developed a tool, the monitor-net folder, to standardise the management information systems of the rheumatic patient within the Italian rheumatology centres. This medical record, available on the web and therefore usable by most Italian rheumatology centres, is a valuable support for the setting up of other national registries.

The SIR has always supported the development of Rheumatology not only at a national but also European level. In this context we include the “Written declaration on Rheumatic Diseases” signed by 405 members of the European Parliament and written in collaboration with the EULAR (European League Against Rheumatism), which brought the rheumatic diseases to the attention of the European Parliament and to the official recognition of their social importance.

Through its non-profit foundation FIRA (Italian Foundation for Arthritis Research), the SIR funds clinical and experimental research projects, conducted collaboratively by multiple centres or by individual Italian researchers. In addition, during the National Congress, young, particularly deserving researchers are rewarded. Special support is also given to research on so-called “orphan” diseases or therapies, which have as yet received scarce consideration by public and private, national and international, funding bodies.

Following the directives of the Finance Act, in the national income tax returns, it is to choose the organisation to which to assign the “5 per mille” *, obviously at no additional charge and regardless of the target of the “8 per mille”.

* “5 per mille” means donating 5 cents from every 1000 declared on tax returns to a charitable organisation.

Whoever intends to donate their support to FIRA, the Italian Foundation for Arthritis Research set up by the SIR on December 22nd 2005, shall insert the association’s tax code number in the dedicated box of their income tax form.

Parlato